MB
ALMS

MPM BioImpact’s Alumis Inc ALMS Stock Holding History

MPM BioImpact’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.8M Sell
2,019,020
-367,509
-15% -$8.55M 3.46% 10
2026
Q1 		$52.6M Sell
2,386,529
-15,463
-0.6% -$387K 4.06% 5
2025
Q4 		$23.4M Buy
+2,401,992
New +$16.8M 2.68% 14

Other funds holding ALMS

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MPM BioImpact's ALMS Position: Q2 2026 in Review

MPM BioImpact reduced its Alumis Inc (ALMS) stake by 15% in Q2 2026, selling an estimated $8.55M and leaving 2,019,020 shares worth $56.8M. The position accounts for 3.46% of the portfolio, ranked #10.

MPM BioImpact first reported a position in ALMS in Q4 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

  • MPM BioImpact held 2,019,020 shares of Alumis Inc worth $56.8M as of Q2 2026.
  • MPM BioImpact sold 367,509 Alumis Inc shares in Q2 2026, an estimated $8.55M.
  • Alumis Inc made up 3.46% of MPM BioImpact's portfolio in Q2 2026, its #10 holding.
  • MPM BioImpact first reported a position in Alumis Inc in Q4 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on MPM BioImpact's 13F filing for Q2 2026, filed 14 Aug 2026.